Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.

Valencia F, Veselenak RL, Bourne N.

Methods Mol Biol. 2013;1030:315-26. doi: 10.1007/978-1-62703-484-5_24.

PMID:
23821278
2.

Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes.

Katsumata K, Chono K, Sudo K, Shimizu Y, Kontani T, Suzuki H.

Molecules. 2011 Aug 25;16(9):7210-23. doi: 10.3390/molecules16097210.

3.

Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.

Bernstein DI, Bravo FJ, Pullum DA, Shen H, Wang M, Rahman A, Glazer RI, Cardin RD.

Antivir Chem Chemother. 2015 Feb;24(1):19-27. doi: 10.1177/2040206614566581.

PMID:
26149263
4.
6.

Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.

Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.

J Infect Dis. 2005 Dec 15;192(12):2117-23. Epub 2005 Nov 11.

PMID:
16288376
8.

Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.

Watkins AM, Dunford PJ, Moffatt AM, Wong-Kai-In P, Holland MJ, Pole DS, Thomas GM, Martin J, Roberts NA, Mulqueen MJ.

Antivir Chem Chemother. 1998 Jan;9(1):9-18.

PMID:
9875372
9.

Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.

Bernstein DI, Cardin RD, Bravo FJ, Earwood J, Clark JR, Li Y, Mishra P, Li C, Nayak BP, Miller AT, Wu TY, Cooke MP, Valiante NM.

Antivir Chem Chemother. 2014 Apr 11;23(5):189-96. doi: 10.3851/IMP2499.

PMID:
23232327
10.

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J, Brown C, Van Nest G, Stanberry LR.

J Virol. 2002 Nov;76(22):11387-96.

11.

Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.

Eide K, Moerdyk-Schauwecker M, Stein DA, Bildfell R, Koelle DM, Jin L.

Antivir Ther. 2010;15(8):1141-9. doi: 10.3851/IMP1694.

PMID:
21149921
12.

Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.

Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T.

Antiviral Res. 2005 Sep;67(3):155-62.

PMID:
16125258
14.

Herpes simplex virus: the importance of asymptomatic shedding.

Koelle DM, Wald A.

J Antimicrob Chemother. 2000 Apr;45 Suppl T3:1-8. Review.

PMID:
10855766
15.
16.

Geldanamycin, a ligand of heat shock protein 90, inhibits herpes simplex virus type 2 replication both in vitro and in vivo.

Li YH, Lu QN, Wang HQ, Tao PZ, Jiang JD.

J Antibiot (Tokyo). 2012 Oct;65(10):509-12. doi: 10.1038/ja.2012.67. Epub 2012 Aug 22.

PMID:
22909975
17.

An update on short-course episodic and prevention therapies for herpes genitalis.

Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L.

Herpes. 2007 Jun;14 Suppl 1:5A-11A. Review.

PMID:
17877886
18.

The anti-HSV-2 effect of alumen: In vitro and in vivo experimental studies.

Hong L, Xu X, Chen L, Li B, Wu D, Hu M, Sun Q, Zhu X, Wu W, Hong S, Ding W, Min J, Xu Q.

J Huazhong Univ Sci Technolog Med Sci. 2011 Dec;31(6):828-33. doi: 10.1007/s11596-011-0685-8. Epub 2011 Dec 16.

PMID:
22173507
19.

Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.

Baumeister J, Fischer R, Eckenberg P, Henninger K, Ruebsamen-Waigmann H, Kleymann G.

Antivir Chem Chemother. 2007;18(1):35-48.

PMID:
17354650
20.

Arginine inactivates human herpesvirus 2 and inhibits genital herpesvirus infection.

Ikeda K, Yamasaki H, Minami S, Suzuki Y, Tsujimoto K, Sekino Y, Irie H, Arakawa T, Koyama AH.

Int J Mol Med. 2012 Dec;30(6):1307-12. doi: 10.3892/ijmm.2012.1149. Epub 2012 Oct 4.

PMID:
23042569

Supplemental Content

Support Center